| abstract |
A compound that binds to a GLP-1 receptor, for use in the treatment of an individual with a hibernating myocardium, wherein said compound is a molecule selected from the group consisting of: exedin-3 (SEQ ID NO: 7) , exedin-4 (SEQ ID NO: 9), and a GLP-1 molecule or biologically active variants thereof, which has up to 5 substitutions, deletions, or additions compared to the GLP-I amide (7-36). |